-
Homoharringtonine: Reliable Cytotoxicity Assays
2026-08-20
This scenario-based guide explains how Homoharringtonine (SKU N1504) can support controlled cell viability, proliferation, and cytotoxicity workflows through defined ribosomal activity, solvent guidance, and storage requirements. It also separates established cancer-biology evidence from emerging SARS-CoV-2 antiviral findings and highlights practical limits for interpretation.
-
Murine RNase Inhibitor for Collision-Aware RNA Workflows
2026-08-20
Murine RNase Inhibitor supports selective RNA degradation prevention in sensitive workflows. This article connects oxidation-resistant RNase control with the latest mechanistic insights into ribosome-associated quality control and explains how to design more interpretable RNA assays.
-
Amitriptyline HCl: From Receptors to Lipidomics
2026-08-19
Explore how Amitriptyline HCl can support phenotype-first neuropharmacology research, from multi-receptor perturbation to lipid and autophagy readouts. A recent fish nodavirus study provides a valuable framework for choosing orthogonal assays without overstating antiviral relevance.
-
WEHI-539: Mapping BCL-XL-Dependent Apoptosis
2026-08-19
WEHI-539 is a selective BCL-XL inhibitor for dissecting mitochondrial apoptosis, cellular dependency, and treatment resistance. This guide focuses on assay interpretation—linking BAK-dependent phenotypes, orthogonal readouts, and cancer stem cell sensitization to a rigorous experimental framework.
-
Amitriptyline HCl: Practical Protocol Guide
2026-08-18
Amitriptyline HCl (SKU B2231) provides a defined small-molecule tool for studying multi-receptor neurotransmitter modulation in in vitro and ex vivo assays. It is suitable for controlled neuropharmacology workflows, but should not be used to infer therapeutic efficacy, disease-model outcomes, or long-term solution stability without additional validation.
-
Fzd5 Links Cholesterol to Wnt Signaling in PDAC
2026-08-18
The reference study identifies Fzd5 as a cholesterol-sensitive Wnt receptor that connects lipid metabolism with receptor palmitoylation, plasma-membrane trafficking, and β-catenin pathway activity in pancreatic ductal adenocarcinoma. Its findings define a mechanistic framework for understanding cholesterol dependence in Wnt-driven tumors and suggest analytical workflows for studying related receptor and biomolecule changes.
-
Frizzled5 Couples Cholesterol to Wnt Signaling
2026-08-17
The reference study identifies Frizzled5 (Fzd5) as a cholesterol-responsive Wnt receptor, showing that cholesterol binding promotes receptor palmitoylation, maturation, and plasma-membrane trafficking. Its experiments connect this lipid-dependent receptor regulation to Wnt/β-catenin activity and pancreatic ductal adenocarcinoma growth, while a competing natural oxysterol suggests a mechanistically focused intervention point.
-
CaP-Pickering Emulsion for mRNA Cancer Vaccines
2026-08-17
The reference study develops a calcium phosphate nanoparticle-stabilized water-in-oil-in-water Pickering emulsion for mRNA cancer vaccination. Its key contribution is to connect cytosolic mRNA delivery with preferential dendritic-cell activation and secondary natural killer-cell stimulation, producing stronger antitumor responses in E.G7 and B16-OVA models.
-
Hydroxytyrosol for Oxidative Stress Assays
2026-08-16
Learn how to deploy Hydroxytyrosol in reproducible oxidative-stress, inflammation, renal, and cardiovascular workflows. This guide connects nicotine-related kidney injury biology with practical dosing, controls, readouts, and troubleshooting for cell-based research.
-
Entecavir (BMS200475): HBV Mechanism and Use
2026-08-15
Entecavir, also known as BMS200475, is a potent and selective HBV DNA polymerase inhibitor for chronic hepatitis B infection therapy. Its strongest evidence supports suppression of HBV replication, including activity against lamivudine-resistant variants, while clinical use requires attention to renal function and rare hematologic events.
-
Osthole, m6A-TGM2, and Rheumatoid Arthritis-ILD
2026-08-14
The reference study identifies a TGM2/Myc/WTAP regulatory circuit that links N6-methyladenosine biology to rheumatoid arthritis progression and associated interstitial lung disease. Its findings position osthole as a mechanistically supported candidate for suppressing RA-fibroblast-like synoviocyte behavior and macrophage-associated lung pathology, while highlighting experimental routes for validating proliferation and DNA-synthesis phenotypes.
-
Ertugliflozin: From SGLT2 Mechanism to Translation
2026-08-14
Ertugliflozin (PF-04971729) offers translational researchers a highly selective way to interrogate renal glucose transport, while its cardiovascular and intestinal model data invite broader—but carefully bounded—questions. This article connects assay design, clinical evidence, and strategic development decisions beyond the typical product-page overview.
-
Direct Mouse Genotyping Kit Plus Workflow Guide
2026-08-13
Build faster, cleaner mouse genotyping workflows for colony screening, transgene detection, and knockout studies without DNA purification. This practical guide connects direct lysate PCR to the EP4–CD36 atherosclerosis model and shows how to optimize assay setup, controls, and troubleshooting.
-
Thrombin Fragment in Fibrin-Matrix Assays
2026-08-13
Use this defined thrombin-derived fragment to build controlled peptide, matrix, and assay-reproducibility workflows without mistaking it for catalytically active full-length thrombin. The guide translates fibrin-matrix angiogenesis findings into practical dosing, controls, storage, and troubleshooting decisions.
-
EdU Flow Cytometry Assay Kits (Cy3) for TNBC
2026-08-12
Translate ferroptosis-focused breast cancer biology into a quantitative S-phase readout with EdU Flow Cytometry Assay Kits (Cy3). The denaturation-free click-chemistry workflow supports cell-cycle profiling, treatment-response studies, and multiplex analysis alongside phenotypic markers.